Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis
BackgroundRadiofrequency ablation (RFA) and chemotherapy are used to treat lung cancer or pulmonary metastases, but no direct comparison of overall survival (OS) has been published. The present study aimed to assess the OS of RFA and/or chemotherapy in patients with lung cancer or pulmonary metastas...
Main Authors: | Ziyi Yang, Xia Lyu, Huilin Yang, Bingbing Wang, Dan Xu, Lingyi Huo, Runzi Zhang, Yingjun Huang, Benshu Diao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1240149/full |
Similar Items
-
Long-Term Survival of Two Patients with Liver Metastases from Advanced Gastric Cancer Treated with Radiofrequency Ablation and Chemotherapy
by: Sung Jin Oh
Published: (2021-02-01) -
Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation
by: Hao Wu, et al.
Published: (2021-01-01) -
Clinical efficacy of chemoembolization with simultaneous radiofrequency ablation for treatment of adrenal metastases from hepatocellular carcinoma
by: Hongjun Yuan, et al.
Published: (2018-07-01) -
Characteristic changes of the ablation zone on contrast-enhanced computed tomography after radiofrequency ablation of hepatic metastases
by: Markus Zimmermann, et al.
Published: (2018-07-01) -
Radiofrequency Ablation for Lung Neoplasms with Isolated Postsurgical Local
Recurrences or Metastases of Non-small Cell Lung Cancer
by: Baodong LIU, et al.
Published: (2014-06-01)